Table 3.
Medication Factor | R 2 | Beta (coefficient) | t | P ‐value |
---|---|---|---|---|
Polypharmacy score | 0.89 | |||
Number of medicines | 0.83 | 8.45 | <0.0001 | |
Drug burden index | 0.21 | 2.17 | 0.047 | |
Medicines associated with harm | 0.73 | |||
Number of medicines | 0.57 | 4.01 | 0.01 | |
Beers medicines | 0.49 | 3.5 | 0.003 | |
Ability to simplify medicines | 0.64 | |||
Number of medicines | 0.44 | 2.41 | 0.03 | |
STOPP criteria | 0.48 | 2.65 | 0.018 |
Variables from the univariate analyses with a P < 0.10 were included in the multivariate stepwise linear regression model and falls‐risk medicine was excluded from the model to avoid collinearity with Drug Burden Index (DBI).
R 2 assesses goodness‐of‐fit of model.